FIELD: pharmaceutical industry, in particular phospholipid-based pharmaceutical composition hawing hepatoprotective and metabolism normalizing activity in form of tablets, pellets, capsules, injection solutions, etc.
SUBSTANCE: claimed composition contains both plant and animal origin phospholipid, essential amino acid such as methionine and threonine, and filler at total phospholipid and amino acid content of 15-80 % in mass ratio of 2:1.
EFFECT: effective pharmaceutical composition having excellent hepatoprotective and lipid, protein, and carbohydrate metabolism normalizing activity.
12 cl, 26 tbl, 98 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION OF HYPOLIPIDEMIC AND HEPATOPROTECTIVE ACTIVITY | 2007 |
|
RU2329051C1 |
PHARMACEUTICAL COMPOSITIONS BASED ON 9-BUTYLAMINO-3,3-DIMETHYL-3,4-DIHYDROACRIDINE-1(2H)-ONE HYDROCHLORIDE FOR THE CORRECTION OF COGNITIVE AND NEUROLOGICAL DISORDERS | 2015 |
|
RU2664439C2 |
ANTI-INFLAMMATORY MEDICINAL AGENT | 2005 |
|
RU2283112C1 |
PHARMACEUTICAL COMPOSITION OF N-(6-PHENYLHEXANOYL)GLYCYL-L-TRYPTOPHAN AMIDE WITH FILM COATING AND THE METHOD OF ITS PRODUCTION | 2013 |
|
RU2663691C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING LIVER DISEASES | 2019 |
|
RU2725622C1 |
COMPOSITION CONTAINING PARTICLES | 2015 |
|
RU2696482C2 |
PHARMACEUTICAL COMPOSITION OF N-(6-PHENYLHEXANOYL)GLYCYL-L-TRYPTOPHAN AMIDE IN SOLID DOSAGE FORM | 2013 |
|
RU2602742C2 |
METHOD OF INDUCING SATIETY | 2015 |
|
RU2690672C2 |
COMPOSITION EXHIBITING PROPERTY FOR BIOLOGICAL MEMBRANE REPAIRING | 1998 |
|
RU2133122C1 |
PHARMACEUTICAL COMPOSITION WITH ENTEROSOLUBLE COATING, METHOD OF ITS PREPARING, METHOD OF TREATMENT OF PATIENTS | 1994 |
|
RU2138254C1 |
Authors
Dates
2006-09-10—Published
2005-06-07—Filed